The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
While more Medicaid beneficiaries have been purged in the span of a year than ever before, enrollment is on track to settle at pre-pandemic levels.
Advocates say two bills under consideration could help migrant communities but that more needs to be done.
Facts don’t support claims by a likely Republican Senate candidate that a federal research laboratory in Montana infected bats with a coronavirus from China before the covid-19 outbreak.
Ketamine, approved by the FDA as an anesthetic in 1970, is emerging as a major alternative mental health treatment, and there are now more than 500 ketamine clinics around the country. But with little regulation and widely varying treatment protocols, it’s a medical “wild West.”
It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.
The head of Montana’s health department said the agency is catching up on a months-long backlog of contracts with organizations that connect people to medical care that left organizations without pay, halted some services, and triggered job cuts.
On this episode of “An Arm and a Leg,” host Dan Weissmann seeks advice for fighting unfair medical bills from an unexpected source: an expert in self-defense.
As national prescription drug distributors and pharmacies restricted the flow of oxycodone and other painkillers in response to the growing opioid crisis, Florida’s most popular grocery store ramped up its sales and distribution of the highly addictive drugs, according to a Tampa Bay Times analysis of federal data.
KFF Health News gives readers a chance to comment on a recent batch of stories.
